Charles River Laboratories stock fell early Wednesday, though the medical research firm beat third-quarter forecasts and raised guidance.
The post Charles River Labs, A Top 2% Medical Stock, Drops Despite Its Beat And Raise appeared first on Investor's Business Daily .